Stay updated on Long-term Safety/Efficacy of Nemolizumab in Atopic Dermatitis Clinical Trial
Sign up to get notified when there's something new on the Long-term Safety/Efficacy of Nemolizumab in Atopic Dermatitis Clinical Trial page.

Latest updates to the Long-term Safety/Efficacy of Nemolizumab in Atopic Dermatitis Clinical Trial page
- Check7 days agoNo Change Detected
- Check14 days agoChange DetectedAdded a consolidated 'Locations' section with numerous regional entries (e.g., Alabama, Arizona, California, etc., plus Australia and European regions) and removed the separate 'X Locations' subsections.SummaryDifference1%

- Check21 days agoNo Change Detected
- Check28 days agoNo Change Detected
- Check36 days agoChange DetectedRevision: v3.3.2 was added, replacing the previous Revision: v3.3.1. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check43 days agoChange DetectedPublications section description updated to indicate publications are automatically filled from PubMed; revision tags updated to v3.3.1 (additions) and v3.2.0 (deletions).SummaryDifference0.0%

- Check50 days agoChange DetectedDeleted the government funding/operating status notice on the page; the study details and endpoints remain unchanged. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check64 days agoChange DetectedTwo screenshots show the same Study Details page for NCT03989206 with only minor formatting differences. No core content changes to the study, outcomes, or locations were observed.SummaryDifference0.1%

- Check79 days agoChange DetectedAdded a new open-label extension study citation for nemolizumab in atopic dermatitis (up to 2 years) with full author list and journal DOI; no deletions observed.SummaryDifference2%

Stay in the know with updates to Long-term Safety/Efficacy of Nemolizumab in Atopic Dermatitis Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Long-term Safety/Efficacy of Nemolizumab in Atopic Dermatitis Clinical Trial page.